Assessment of the use of hypolipidemic agents (HAs), mainly statins, in elderly subjects aged 80 years and more in Burgundy: analysis of 13,211 patients.

Patrick Manckoundia, Mathieu Lorenzini, Anne Disson-Dautriche, Jean-Michel Petit, Bernard Lorcerie, Emmanuel Debost, Didier Menu, Pierre Pfitzenmeyer

Service de Médecine Interne Gériatrie, Hôpital de Champmaillot, CHU, 2 rue Jules Violle, F-21079 Dijon Cedex, France. patrick.manckoundia@chu-dijon.fr

Archives of gerontology and geriatrics 2012 Jul-Aug

filter terms:

Only few studies have investigated the use of HA in elderly subjects and there are no data in very elderly subjects. We assessed the prescription of HA and analyzed the relationship between such prescriptions and frailty markers among persons aged 80 and more in an observational study. We recorded the prescriptions for 13,211 patients aged 80-109 years and affiliated to the "Mutualité-Sociale-Agricole (MSA)" of Burgundy over a 1-month period. The prescription of a HA among all included patients, and the existence of serious long-term disease(s) (LTD), polypharmacy or a prescription of cardiovascular drugs among patients receiving a HA were recorder. Among the 13,211 patients, 3412 aged 80-98 years were treated with an HA. The main HA were statins (70.4%), and fibrates were used in 27.3% of cases. Of these 3412 patients, 2250 had one or several LTD mainly coronaropathy, hypertension, diabetes mellitus or peripheral artery disease. The mean number of drugs per prescription was 6.37. Among subjects treated with HA, 40% also received antiplatelets, 35.6% β-blockers and 30% inhibitors of the renin-angiotensin system. For 99% of the patients, the prescription of HA was a renewal. Prescribers were mainly general practitioners (96.8%). Statins are the most widely prescribed HA even among very elderly subjects. However, after 80 years the prescription of HA, mainly statins, decreases with aging. This could be explained by polypathology, polypharmacy and the deterioration in metabolic functions which are markers of frailty. This study should encourage research into the use of statins in very elderly subjects. Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Citation

Patrick Manckoundia, Mathieu Lorenzini, Anne Disson-Dautriche, Jean-Michel Petit, Bernard Lorcerie, Emmanuel Debost, Didier Menu, Pierre Pfitzenmeyer. Assessment of the use of hypolipidemic agents (HAs), mainly statins, in elderly subjects aged 80 years and more in Burgundy: analysis of 13,211 patients. Archives of gerontology and geriatrics. 2012 Jul-Aug;55(1):101-5